Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients

Guo, Yu; Xia, Wei; Peng, Xuehua; Shao, Jianbo

doi:10.3389/fped.2020.602083

Cited by 12 publications

(10 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, researchers focused on clinically relevant research of COVID-19 in children, such as the diagnosis (25,26), clinical features (27,28), clinical management (29)(30)(31), and treatment of COVID-19 in combination with other diseases (32,33). The articles by Shao are mainly related to the differentiation of COVID-19 and other pulmonary infections in children (34)(35)(36), clinical and computed tomography features (37)(38)(39)(40), and COVID-19-related immunology studies (41)(42)(43).…”

Section: Cluster Analysis Of Abstractmentioning

confidence: 99%

Global Research Trends in Pediatric COVID-19: A Bibliometric Analysis

Wang

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

BackgroundCoronavirus disease 2019 (COVID-19) emerged in 2019 and has since caused a global pandemic. Since its emergence, COVID-19 has hugely impacted healthcare, including pediatrics. This study aimed to explore the current status and hotspots of pediatric COVID-19 research using bibliometric analysis.MethodsThe Institute for Scientific Information Web of Science core collection database was searched for articles on pediatric COVID-19 to identify original articles that met the criteria. The retrieval period ranged from the creation of the database to September 20, 2021. A total of 3,561 original articles written in English were selected to obtain data, such as author names, titles, source publications, number of citations, author affiliations, and countries where the studies were conducted. Microsoft Excel (Microsoft, Redmond, WA) was used to create charts related to countries, authors, and institutions. VOSviewer (Center for Science and Technology Studies, Leiden, The Netherlands) was used to create visual network diagrams of keyword, author, and country co-occurrence.ResultsWe screened 3,561 publications with a total citation frequency of 30,528. The United States had the most published articles (1188 articles) and contributed the most with author co-occurrences. The author with the most published articles was Villani from the University of Padua, Italy. He also contributed the most co-authored articles. The most productive institution was Huazhong University of Science and Technology in China. The institution with the most frequently cited published articles was Shanghai Jiao Tong University in China. The United States cooperated most with other countries. Research hotspots were divided into two clusters: social research and clinical research. Besides COVID-19 and children, the most frequent keywords were pandemic (251 times), mental health (187 times), health (172 times), impact (148 times), and multisystem inflammatory syndrome in children (MIS-C) (144 times).ConclusionPediatric COVID-19 has attracted considerable attention worldwide, leading to a considerable number of articles published over the past 2 years. The United States, China, and Italy have leading roles in pediatric COVID-19 research. The new research hotspot is gradually shifting from COVID-19 and its related clinical studies to studies of its psychological and social impacts on children.

show abstract

Section: Cluster Analysis Of Abstractmentioning

confidence: 99%

Global Research Trends in Pediatric COVID-19: A Bibliometric Analysis

Wang

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…On the other hand, MP infection can be diagnosed by high-resolution computed tomography (HRCT) examination, because it can observe lung lesions from multiple levels, and it is easy to accurately locate and clarify the degree and scope of lesions. Pulmonary function suggests severe MPP involving the large airways, with concomitant stenosis and occlusion of the lower small airways [ 8 ]. Lung structural abnormalities are common in school-aged children after MPP surgery, but there are few studies on imaging, especially HRCT, and their correlation with PVF during the course of the disease (CoD).…”

Section: Introductionmentioning

confidence: 99%

Diagnosis and Prognostic Analysis of Mycoplasma pneumoniae Pneumonia in Children Based on High‐Resolution Computed Tomography

Leng¹,

Yang²,

Wang³

2022

Contrast Media & Molecular Imaging

View full text Add to dashboard Cite

Mycoplasma pneumoniae (MP) is defined as a common cause of pulmonary infections and accounts for up to four over ten of pneumonia in children over age 5. This study was aimed to explore the diagnosis and prognosis of mycoplasma pneumoniae pneumonia (MPP) in children using high-resolution computed tomography (CT) (HRCT). 71 children hospitalized with MPP were undertaken as the research objects to observe the incidence rate, occurrence time, and duration of the clinical symptoms and pathological signs. The chest HRCT and pulmonary ventilation function (PVF) were examined in the acute phase, the second phase re-examination period, and the third phase re-examination period. Relevant indicators were statistically analyzed to determine the change rules of chest HRCT and PVF and correlation between the two. Clinically, the children with MPP suffered from fever, cough, and sore throat. In addition to the above symptoms, children with MPP had different degrees of PVF impairment. Compared with the group with normal HRCT results, the forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF), forced expiratory flow at 25% forced expiratory volume (FEF25), forced expiratory flow at 50% forced expiratory volume (FEF50), forced expiratory flow at 75% forced expiratory volume (FEF75), and maximum mid-expiratory flow (MMEF75/25) of children in bronchopneumonia group, segmental pneumonia group, and lobar pneumonia group were obviously reduced, showing statistically great differences (P < 0.05). Compared with the case in acute phase, the PVF indicators of children in the re-examination phases were much higher, with greatly statistical differences (P < 0.05). In children with MPP, both the large and small airways were affected, but the recovery of the small airways was slow. Pulmonary HRCT and PVF can be undertaken as important indicators to judge the severity and prognosis of MPP in school-age children.

show abstract

“…A similar investigation was performed in pediatric patients using 80 patients with COVID-19 and 95 patients with M. pneumoniae CAP by Guo et al [16]. Compared to COVID-19 and M. pneumoniae, fever and cough are observed more common in M. pneumoniae CAP.…”

Section: Discussionmentioning

confidence: 76%

Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia

Miyashita

Nakamori

Ogata

et al. 2022

JCM

View full text Add to dashboard Cite

Mycoplasmapneumoniae is one of the major causative pathogens of community-acquired pneumonia (CAP). M. pneumoniae CAP is clinically and radiologically distinct from bacterial CAPs. One feature of the Japanese Respiratory Society (JRS) guidelines is a trial to be carried out to differentiate between M. pneumoniae pneumonia and bacterial pneumonia for the selection of antibiotics. The purpose of the present study was to clarify the clinical and radiological differences of the M. pneumoniae CAP and coronavirus disease 2019 (COVID-19) CAP. This study was conducted at 5 institutions and assessed a total of 210 patients with M. pneumoniae CAP and 956 patients with COVID-19 CAP. The median age was significantly younger in patients with M. pneumoniae CAP than COVID-19 CAP. Among the clinical symptoms, cough and sputum were observed more frequently in patients with M. pneumoniae CAP than those with COVID-19 CAP. However, the diagnostic specificity of these findings was low. In contrast, loss of taste and anosmia were observed in patients with COVID-19 CAP but not observed in those with M. pneumoniae CAP. Bronchial wall thickening and nodules (tree-in-bud and centrilobular), which are chest computed tomography (CT) features of M. pneumoniae CAP, were rarely observed in patients with COVID-19 CAP. Our results demonstrated that there were two specific differences between M. pneumoniae CAP and COVID-19 CAP: (1) the presence of loss of taste and/or anosmia and (2) chest CT findings.

show abstract

Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients

Cited by 12 publications

References 19 publications

Global Research Trends in Pediatric COVID-19: A Bibliometric Analysis

Global Research Trends in Pediatric COVID-19: A Bibliometric Analysis

Diagnosis and Prognostic Analysis of Mycoplasma pneumoniae Pneumonia in Children Based on High‐Resolution Computed Tomography

Clinical Differences between Community-Acquired Mycoplasma pneumoniae Pneumonia and COVID-19 Pneumonia

Contact Info

Product

Resources

About